A new and extraordinary $22 million gift to the University of Michigan Health System is making possible a new and extraordinary institute — one with a mission of supporting fundamental research to advance the understanding of the causes, treatment and prevention of a broad range of human diseases.
A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumour fails to respond to the cutting edge therapy.
Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington’s disease – a fatal disorder for which there is currently no cure or even a treatment to slow the disease.
Prehypertensive middle-aged men who have high levels of trait anger – a tendency to experience anger across a range of situations – are at increased risk of progressing to hypertension and developing coronary heart disease, according to a secondary analysis of a large population-based study.
Because racial or ethnic differences in response to antihypertensive drug therapies may contribute to disparities in cardiovascular disease, this systematic review of 28 studies attempts to (1) identify racial differences in the efficacy of antihypertensive drug therapies and (2) quantify the number and proportion of racial and ethnic minorities participating in these clinical trials.
Consuming large amounts of caffeine while taking acetaminophen, one of the most widely used painkillers in the United States, could potentially cause liver damage, according to a preliminary laboratory study reported in the Oct. 15 print issue of ACS’ Chemical Research in Toxicology, a monthly journal.
The European Commission has approved Exelon® patch (rivastigmine transdermal patch), an innovative way to deliver this effective medicine to patients suffering from mild to moderately severe Alzheimer’s disease.
WHO is expanding its programme to train health care staff in low- and middle-income countries in essential emergency, basic surgery and anaesthesia skills. The programme, which already exists in 22 countries, will boost the capacity of first-level health facilities (rural or district hospitals and health centres) to deal with simple but essential surgery in a growing number of developing regions.
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has issued an approvable letter for the new drug application (NDA) for Lamictal®XR™ (lamotrigine) Extended-Release Tablets.
The University of Rochester Medical Center received $1.5 million to develop a blood test for concussions by isolating proteins that can predict memory loss, chronic headaches or other neurological problems.